Endotoxin initiates the systemic inflammatory response, haemodynamic c
hanges, and multi-organ failure that may occur as a consequence of sys
temic gram-negative bacterial infection. The serum protein lipopolysac
charide-binding protein (LBP) binds to the lipid A component of bacter
ial endotoxin and facilitates its delivery to the CD14 antigen on the
macrophage, where proinflammatory cytokines are released and a cascade
of host mediators is initiated. The neutrophil granular protein bacte
ricidal/permeability-increasing protein (BPI) competes with LBP for en
dotoxin binding and functions as a molecular antagonist of LBP-endotox
in interactions. We have measured concentrations of both proteins in b
ody fluids from 49 consecutive patients. In 16 of 17 samples of fluid
from closed-space infections, BPI was present in greater concentration
than LBP (median BPI/LBP ratio 7.6 [95% CI 2.32-22.1]), The ratio of
BPI and LBP was not significantly different from 1.0 in abdominal flui
d from 10 patients with peritonitis (ratio 0.235 [0.18-0.47]), whereas
the BPI/LBP ratio was low in 22 non-infected body fluids (0.01 [0.001
-0.04]) and concentrations of both proteins approached those in normal
human plasma. BPI concentrations were directly correlated with the qu
antity of neutrophils within clinical samples (r(s) = 0.81, p < 0.0001
). Thus, within abscess cavities BPI is available in sufficient quanti
ties for effective competition with LBP for endotoxin. BPI may attenua
te the local inflammatory response and the systemic toxicity of endoto
xin release during gram-negative infections.